KVV41401
HSV-2/HHV-2 gG/US4
Colorimetric
Plasma, Serum
Quantitative
1.56 - 100 ng/mL
0.65 ng/mL
CV<15%
80-120%
2-8 ℃
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Association between human herpes simplex virus and severe headache or migraine among aged 20-49 years: a cross-sectional study., PMID:39440252
Phytochemical profiling, antiviral activities, molecular docking, and dynamic simulations of selected Ruellia species extracts., PMID:38965294
Lactobacillus rhamnosus GG Regulates Host IFN-I Through the RIG-I Signalling Pathway to Inhibit Herpes Simplex Virus Type 2 Infection., PMID:37624569
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G., PMID:36114130
Identification of the Cleavage Domain within Glycoprotein G of Herpes Simplex Virus Type 2., PMID:33322659
Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population., PMID:30814317
Expression and characterization of the soluble form of recombinant mature HSV-2 glycoprotein G for use in anti-HSV-2 IgG serodiagnostic immunoassay., PMID:29104048
Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG., PMID:28332725
Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections., PMID:28238255
Diagnosis of human herpes virus 1 and 2 (HHV-1 and HHV-2): use of a synthetic standard curve for absolute quantification by real time polymerase chain reaction., PMID:28225902
Detection systems for antibody responses against herpes B virus., PMID:32110687
Herpes simplex virus particles interact with chemokines and enhance cell migration., PMID:27692045
False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands., PMID:26755775
[EFFECTIVENESS OF POLYCATIONIC NANOPARTICLES OF POLYETHYLENEIMINE-POLYHYDROZIDE-CHITOSAN (PEI-PG-OCHG) AS A VECTOR FOR SMALL INTER- FERING RNA, DIRECTED TO SUPPRESS HERPES SIMPLEX TYPE 2 VIRUS REPLICATION]., PMID:26259267
Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization., PMID:25625471
Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection., PMID:25611061
Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential., PMID:25532518
Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies., PMID:25377426
Impact of HIV-1 infection on herpes simplex virus type 2 genetic variability among co-infected individuals., PMID:25174847
IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections., PMID:24496316
Novel deletion in glycoprotein G forms a cluster and causes epidemiologic spread of herpes simplex virus type 2 infection., PMID:23861013
Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology., PMID:23514126
Evaluation of antibodies against glycoprotein D (gD) and glycoprotein G (gG) in HSV-1 infected individuals' serum samples., PMID:22696877
Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis., PMID:22491453
Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses., PMID:22319442
Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling., PMID:22318154
Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006., PMID:22085620
Characterization of herpes simplex virus clinical isolate Y3369 as a glycoprotein G variant and its bearing on virus typing., PMID:21658271
Prevalence and risk factors for herpes simplex infection among patients at high risk for HIV infection in Brazil., PMID:21595666
Structure activity relationship of dendrimer microbicides with dual action antiviral activity., PMID:20808791
A 12-year molecular survey of clinical herpes simplex virus type 2 isolates demonstrates the circulation of clade A and B strains in Germany., PMID:20488747
The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies., PMID:20171247
Herpes simplex virus type-2 in Egyptian patients with bladder cancer or cystitis., PMID:20041869
Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2., PMID:20007366
[Culture of HSV-2 and cloning of specific fragment of the gG-2 gene]., PMID:19452693
[Genital herpes]., PMID:19177764
Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing., PMID:18955387
Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera., PMID:17989200
A monocyte-specific peptide from herpes simplex virus type 2 glycoprotein G activates the NADPH-oxidase but not chemotaxis through a G-protein-coupled receptor distinct from the members of the formyl peptide receptor family., PMID:17947682
Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligo- and polysaccharide inhibitors of virus attachment to cells., PMID:17928351
Fatal intrauterine infection by herpes simplex virus type 2 in an infant from a mother lacking seroreactivity to glycoprotein G., PMID:17464869
Amplification and cloning of herpes simplex virus type 2 glycoprotein G from an Iranian isolate., PMID:19069897
[Expression of multi-copy and immuno-reactivity of recombinant type-specific epitope of herpes simplex virus type 1]., PMID:16894929
Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains., PMID:16825377
Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts., PMID:16760320
Comparison of immunoassays for differentiation of herpes simplex virus type 1 and 2 antibodies., PMID:16758036
Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study., PMID:16709538
Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA., PMID:16225691
A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions., PMID:15699157
Production of herpes B virus recombinant glycoproteins and evaluation of their diagnostic potential., PMID:15695655
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
